Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

10.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

6.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CORONAVIRUS SARS-COV-2 MODIFIES ANTITUMOR REDOX STATUS OF BLOOD AND INTERCELLULAR MATRIX IN METASTATIC COLORECTAL CANCER PATIENTS (A PILOT STUDY).

Experimental oncology·2024
Same author

THE CHANGES OF NO LEVEL AND RNase ACTIVITY IN TUMOR TISSUE ACCOMPANYING THE PROGRESSION OF PROSTATE CANCER.

Experimental oncology·2022
Same author

Redox dependent features of tumors, adipose tissue, neutrophiles and platelets in patients with metastatic colorectal cancer.

Experimental oncology·2021
Same author

Drag reducing polymers attenuate adverse effects of ischemia-reperfusion upon resection of liver metastases modeled by MC38 mouse colon adenocarcinomama.

Experimental oncology·2020
Same author

Single-walled carbon nanotubes loaded hydroxyapatite-alginate beads with enhanced mechanical properties and sustained drug release ability.

Progress in biomaterials·2020
Same author

Molecular mechanisms of oxidation damage and liver cell dysfunction in patients with metastatic colorectal cancer.

Experimental oncology·2019

Related Experiment Video

Updated: Apr 10, 2026

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
09:45

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

9.0K

Using water-soluble C60 fullerenes in anticancer therapy.

S V Prylutska1, A P Burlaka2, P P Klymenko3

  • 1Institute of Biology, Kyiv National Taras Shevchenko University, Volodymyrska Str., 64, 01601 Kyiv, Ukraine.

Cancer Nanotechnology
|June 13, 2015
PubMed
Summary

Water-soluble C60 fullerenes effectively inhibited malignant tumor growth in mice. This suggests potential for C60 fullerenes in novel anticancer therapies due to their antioxidant and receptor-blocking properties.

Keywords:
C60 fullerenesHistological dataIncreasing of animal lifeLewis lung carcinomaMetastasis inhibition indexMice line C57Bl/6JSurvival of animalsTumor growth inhibition

More Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.6K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.7K

Related Experiment Videos

Last Updated: Apr 10, 2026

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
09:45

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

9.0K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.6K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.7K

Area of Science:

  • Nanomedicine
  • Oncology
  • Biochemistry

Background:

  • Malignant tumors pose a significant global health challenge.
  • Novel therapeutic strategies are continuously sought to improve cancer treatment outcomes.
  • Fullerenes, particularly C60, are being investigated for their unique physicochemical properties.

Purpose of the Study:

  • To evaluate the efficacy of water-soluble C60 fullerenes in inhibiting the growth of transplanted malignant tumors in a preclinical mouse model.
  • To explore the underlying mechanisms responsible for the observed antitumor effects of C60 fullerenes.

Main Methods:

  • In vivo growth experiments involving transplanted malignant tumors in mice.
  • Administration of water-soluble C60 fullerenes to experimental groups.
  • Assessment of tumor growth inhibition and analysis of potential mechanisms.

Main Results:

  • Water-soluble C60 fullerenes demonstrated significant inhibition of transplanted malignant tumor growth.
  • The antitumor effect is attributed to the potent antioxidant activity of C60 fullerenes.
  • C60 fullerenes were found to block specific cell receptors, such as endothelial growth factor receptors.

Conclusions:

  • Water-soluble C60 fullerenes exhibit potent anticancer properties in a preclinical setting.
  • The findings support the potential application of C60 fullerenes as a therapeutic agent in anticancer therapy.
  • Further research into C60 fullerene-based cancer treatments is warranted.